Ardent Health Inc.
ARDT | NYSE
$10.61
+$0.13 (+1.24%)
At close: Sep 21, 2026, 4:00 PM ET
$10.80
+$0.19 (+1.79%)
Pre-market:
Sep 22, 2026, 9:16 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.62B | 1.6B | 1.61B | 1.58B | 1.65B | 1.5B | 1.61B | 1.45B | 1.47B | 1.44B | 1.35B | 1.38B | 1.37B | 1.32B |
Cost of Revenue | 1.53B | 1.36B | 928.92M | 676.96M | 270.64M | 258.86M | 653.97M | 251.86M | 259.39M | 257.78M | 598.12M | 595.58M | 598.29M | 34.7M |
Gross Profit | 97.11M | 246.06M | 676.16M | 899.78M | 1.37B | 1.24B | 952.32M | 1.2B | 1.21B | 1.18B | 747.91M | 782.15M | 770.44M | 1.28B |
Operating Income | 43.2M | 80.91M | 104.75M | 254.33M | 137.28M | 67.09M | 336.79M | 70.38M | -157.41M | 75.83M | 171.88M | 225.14M | 221.17M | 54.15M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 43.2M | 74.59M | 92.37M | -2.2M | 121.99M | 74.2M | 167.25M | 57.07M | 82.18M | 56.56M | 8.83M | 45.97M | 67.82M | 29M |
Net Income | 16.9M | 39.85M | 44.96M | -23.48M | 72.95M | 41.38M | 114.2M | 26.32M | 42.77M | 27.05M | -4.15M | 20.84M | 33.08M | 4.14M |
Selling & General & Admin | n/a | n/a | 376.24M | 645.46M | 1.03B | 1B | 615.53M | 973.11M | 957.91M | 948.26M | 576.03M | 557.01M | 549.28M | 885.37M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 53.91M | 165.15M | 195.17M | n/a | 203.01M | 166.97M | n/a | 154.47M | 411.02M | 157.18M | n/a | n/a | n/a | 342.77M |
Operating Expenses | 53.91M | 165.15M | 571.4M | 645.46M | 1.24B | 1.17B | 615.53M | 1.13B | 1.37B | 1.11B | 576.03M | 557.01M | 549.28M | 1.23B |
Interest Expense | 12.57M | 10.74M | 12.38M | 13.91M | 14.73M | 14.18M | 13.53M | 14.63M | 18.16M | 17.04M | 9.57M | 19.04M | 18.69M | 18.12M |
Selling & Marketing Expenses | n/a | n/a | n/a | 340.37M | n/a | n/a | 329.23M | n/a | n/a | n/a | 310.87M | 310.47M | 314.56M | n/a |
Cost & Expenses | 1.58B | 1.52B | 1.5B | 1.32B | 1.51B | 1.43B | 1.27B | 1.38B | 1.63B | 1.36B | 1.17B | 1.15B | 1.15B | 1.26B |
Income Tax Expense | 8.51M | 16.1M | 18.11M | -3.41M | 26.29M | 15.23M | 26.36M | 11.06M | 15.22M | 10.71M | -1.95M | 7.26M | 12.11M | 5.22M |
Shares Outstanding (Basic) | 141.69M | 141.27M | 140.76M | 140.57M | 140.22M | 140.06M | 142.75M | 137.11M | 142.76M | 143.26M | 142.11M | 140.96M | 142.76M | 143.26M |
Shares Outstanding (Diluted) | 143.05M | 141.78M | 141.45M | 141.24M | 141.11M | 140.7M | 132.75M | 137.54M | 142.76M | 143.26M | 142.11M | 140.96M | 142.76M | 143.26M |
EPS (Basic) | 0.12 | 0.28 | 0.32 | -0.17 | 0.52 | 0.30 | 0.80 | 0.19 | 0.30 | 0.19 | -0.05 | 0.15 | 0.23 | 0.03 |
EPS (Diluted) | 0.12 | 0.28 | 0.32 | -0.17 | 0.52 | 0.29 | 0.86 | 0.19 | 0.30 | 0.19 | -0.05 | 0.15 | 0.23 | 0.03 |
EBITDA | 71.98M | 128.32M | 145.79M | 55.61M | 176.03M | 124.58M | 195.43M | 108.47M | 136.66M | 108.96M | 62.17M | 100.5M | 112.34M | 81.82M |
EBIT | 30.63M | 85.33M | 104.75M | 16.46M | 136.72M | 88.37M | 157.57M | 71.7M | 100.34M | 73.61M | 26.19M | 65.01M | 77.67M | 47.12M |
Depreciation & Amortization | 41.34M | 42.99M | 41.04M | 39.16M | 39.31M | 36.2M | 37.85M | 36.77M | 36.31M | 35.35M | 35.98M | 35.49M | 34.67M | 34.7M |
Add to Watchlist
Select watchlists to add or remove ARDT